Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

QR Code

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

None

Saved in:

Bibliographic Details
Main Authors:	Takahashi, Naoto, Miura, Masatomo
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25655
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug- Induced Pneumonitis: A Rare Complication of Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukemia
by: Lazareva, O.V., et al.
Published: (2012)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

Chronic myeloid leukemia — before and after imatinib (part II)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)
by: L. A. Antipova, et al.
Published: (2022-11-01)

Bacillus cereus Sepsis in the Treatment of Acute Myeloid Leukemia
by: Inoue, Daichi, et al.
Published: (2012)

The Value of Molecular Response in Chronic Myeloid Leukemia: The Present and the Future
by: Falchi, Lorenzo, et al.
Published: (2012)

Bosutinib for Successful Treatment‐Free Remission in Chronic Myeloid Leukemia
by: Yuki Fujioka, et al.
Published: (2025-05-01)

PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
by: Takahashi, Shinichiro
Published: (2011)

Therapy of Acute Myeloid Leukemia
by: El-Cheikh, Jean, et al.
Published: (2012)

Pediatric Acute Myeloid Leukemia
by: Zwaan, C. Michel, et al.
Published: (2011)

Vitamin D and Acute Myeloid Leukemia
by: Lee, Hun Ju, et al.
Published: (2011)

Apoptosis and Apoptosis Modulators in Myeloid Leukemia
by: Abdullah, Maha, et al.
Published: (2011)

Pro-Inflammatory Cytokines in Patients With Chronic Phase-Chronic Myeloid Leukaemia Treated With Imatinib: Any Role in the Monitoring of Treatment Response?
by: Kehinde A. Taiwo, et al.
Published: (2025-06-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

New Molecular Markers in Acute Myeloid Leukemia
by: Iñigo, Silvia de la Iglesia, et al.
Published: (2011)

Role of Signaling Pathways in Acute Myeloid Leukemia
by: Abdullah, Maha, et al.
Published: (2011)

Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib
by: Ikhlas Khammas, et al.
Published: (2025-06-01)

Targeting the Chronic Myeloid Leukemia Stem Cell: A Paradigm for the Curative Treatment of Human Malignancies
by: Woolfson, Adrian, et al.
Published: (2011)

Molecularly Targeted Therapy: Imatinib and Beyond
by: Poklepovic, Andrew, et al.
Published: (2012)

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming
by: Lan Yang, et al.
Published: (2025-07-01)

Long-Term Safety and Efficacy of Imatinib in Chronic Myeloid Leukemia: Real-World Evidence from a Single-Center Study
by: İsmail Can Kendir, et al.
Published: (2025-06-01)

Hematopoietic Stem Cell in Acute Myeloid Leukemia Development
by: Bydlowski, Sérgio Paulo, et al.
Published: (2012)

DNA Repair in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Szmigielska-Kaplon, Anna, et al.
Published: (2011)

Genetic Alterations and Their Clinical Implications in Acute Myeloid Leukemia
by: Hou, Hsin-An, et al.
Published: (2011)

Biomarkers and Therapeutic Drug Monitoring in Psychiatry
by: Lozano, R., et al.
Published: (2012)

Therapeutic Drug Monitoring of Antiepileptic Medications
by: Krasowski, Matthew D.
Published: (2011)

Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation
by: A. G. Turkina, et al.
Published: (2024-12-01)

Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia
by: Fatemeh Ensafi Talemi, et al.
Published: (2025-01-01)

Ser/Thr Phosphatases: The New Frontier for Myeloid Leukemia Therapy?
by: Smith, Amanda M., et al.
Published: (2011)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2024-05-01)

Diagnostic Approach in Acute Myeloid Leukemias in Line with WHO 2008 Classification
by: Goyal, Manu, et al.
Published: (2012)

Clinical and Biological Relevance of Gene Expression Profiling in Acute Myeloid Leukemia
by: Gruszka, Alicja M., et al.
Published: (2012)